Recurrent uterine serous carcinoma with a germline pathogenic BRCA2 variant treated using olaparib: A case report

• 主要な著者: Kayo Inoue (著者), Hiroshi Tsubamoto (著者), Tomoko Ueda (著者), Chihiro Tajima (著者), Nami Nakagomi (著者)
• フォーマット: 図書
• 出版事項: Elsevier, 2020-05-01T00:00:00Z.
• 主題: article
• オンライン･アクセス: Connect to this object online.

A germline pathogenic variant in BRCA2 was secondarily found through genomic sequencing of uterine serous carcinoma. Clinical response to olaparib was observed in recurrent uterine serous carcinoma with a germline BRCA2 mutation. Here, we report, for the first time, a long-term clinical response to...